FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula
or tautomer thereof 
or enantiomer or physiologically acceptable salt, where R1 is o-bromo, R2 is n-fluoro, R3 is C1-C4 alkyl, R6 is thiazolyl-2-yl, X is methylene and Z is morpholinyl. The invention also relates to methods of producing (versions) compounds of formula (I) and (Ia). The compound of formula (I) or (Ia) is used to prepare a pharmaceutical composition for treating or preventing HBV infections and HBV-induced diseases such as hepatitis B.
EFFECT: bromophenyl substituted thiazolyl dihydropyrimidines for HBV infection control.
20 cl, 7 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2013 |
|
RU2655914C9 |
| PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE PRODUCTS THEREOF | 2014 |
|
RU2697707C1 |
| PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF | 2014 |
|
RU2688193C1 |
| DIHYDROPYRIMIDIN COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS | 2015 |
|
RU2682672C2 |
| DIHYDROPYRIMIDINES, INTERMEDIATE PRODUCTS AND MEDICINAL AGENT | 1999 |
|
RU2245881C9 |
| HEPATITIS B VIRUS INHIBITOR (HBV) | 2019 |
|
RU2736975C1 |
| NOVEL DERIVATIVES OF ACETAMIDE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND PROTEASE INHIBITORS BASED ON THEREOF | 1997 |
|
RU2181360C2 |
| COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR | 2016 |
|
RU2718917C2 |
| TRIAZOLO-PYRIMIDINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2802866C2 |
| CHROMENONE COMPOUNDS AS PI3-KINASE INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2598028C2 |
